hca healthcare inc. - HCA

HCA

Close Chg Chg %
493.52 20.24 4.10%

Closed Market

513.76

+20.24 (4.10%)

Volume: 1.46M

Last Updated:

Feb 5, 2026, 3:59 PM EDT

Company Overview: hca healthcare inc. - HCA

HCA Key Data

Open

$495.54

Day Range

494.60 - 517.67

52 Week Range

295.00 - 527.55

Market Cap

$112.65B

Shares Outstanding

228.19M

Public Float

156.36M

Beta

1.37

Rev. Per Employee

N/A

P/E Ratio

17.43

EPS

$20.49

Yield

58.34%

Dividend

$0.78

EX-DIVIDEND DATE

Mar 17, 2026

SHORT INTEREST

N/A

AVERAGE VOLUME

1.16M

 

HCA Performance

1 Week
 
1.10%
 
1 Month
 
4.57%
 
3 Months
 
3.57%
 
1 Year
 
53.28%
 
5 Years
 
179.22%
 

HCA Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 28
Full Ratings ➔

About hca healthcare inc. - HCA

HCA Healthcare, Inc. is a health care services company engaged in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities. The firm operates general and acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services, and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was founded by Dr. Thomas F. Frist, Jr in 1968 and is headquartered in Nashville, TN.

HCA At a Glance

HCA Healthcare, Inc.
One Park Plaza
Nashville, Tennessee 37203-6527
Phone 1-615-344-9551 Revenue 75.60B
Industry Hospital/Nursing Management Net Income 6.78B
Sector Health Services 2025 Sales Growth 7.078%
Fiscal Year-end 12 / 2026 Employees N/A
View SEC Filings

HCA Valuation

P/E Current 17.624
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 16.482
Price to Sales Ratio 1.479
Price to Book Ratio N/A
Price to Cash Flow Ratio 8.85
Enterprise Value to EBITDA 10.484
Enterprise Value to Sales 2.148
Total Debt to Enterprise Value 0.298

HCA Efficiency

Revenue/Employee N/A
Income Per Employee N/A
Receivables Turnover 6.957
Total Asset Turnover 1.258

HCA Liquidity

Current Ratio 0.965
Quick Ratio 0.864
Cash Ratio 0.064

HCA Profitability

Gross Margin 15.827
Operating Margin 15.827
Pretax Margin 13.005
Net Margin 8.974
Return on Assets 11.285
Return on Equity N/A
Return on Total Capital 16.031
Return on Invested Capital 18.06

HCA Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital 114.242
Total Debt to Total Assets 79.62
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 102.689
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Hca Healthcare Inc. - HCA

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
60.23B 64.97B 70.60B 75.60B
Sales Growth
+2.52% +7.86% +8.67% +7.08%
Cost of Goods Sold (COGS) incl D&A
51.18B 55.34B 60.06B 63.63B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
2.97B 3.08B 3.31B 3.52B
Depreciation
- 2.94B 3.05B 3.29B
Amortization of Intangibles
- 28.00M 25.00M 18.00M
COGS Growth
+4.29% +8.13% +8.52% +5.96%
Gross Income
9.05B 9.63B 10.55B 11.96B
Gross Income Growth
-6.46% +6.34% +9.56% +13.44%
Gross Profit Margin
+15.03% +14.82% +14.94% +15.83%
2022 2023 2024 2025 5-year trend
SG&A Expense
- - - -
-
Research & Development
- - - -
-
Other SG&A
- - - 32.86B
-
SGA Growth
- - - -
-
Other Operating Expense
- - - -
-
Unusual Expense
- - - 78.00M
-
EBIT after Unusual Expense
8.97B 9.63B 10.55B 11.96B
Non Operating Income/Expense
1.34B 17.00M 37.00M 115.00M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
45.00M 22.00M 23.00M 78.00M
Interest Expense
1.74B 1.94B 2.06B 2.25B
Interest Expense Growth
+13.73% +11.44% +6.35% +9.07%
Gross Interest Expense
1.74B 1.94B 2.06B 2.25B
Interest Capitalized
- - - -
-
Pretax Income
8.58B 7.71B 8.52B 9.83B
Pretax Income Growth
-12.74% -10.19% +10.60% +15.36%
Pretax Margin
+14.24% +11.86% +12.07% +13.01%
Income Tax
1.75B 1.61B 1.87B 2.05B
Income Tax - Current - Domestic
- 1.43B 1.33B 1.41B
Income Tax - Current - Foreign
- 18.00M 3.00M 20.00M
Income Tax - Deferred - Domestic
- 288.00M 262.00M 425.00M
Income Tax - Deferred - Foreign
- 12.00M 19.00M 7.00M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
45.00M 22.00M 23.00M 78.00M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
6.83B 6.09B 6.66B 7.78B
Minority Interest Expense
1.19B 849.00M 897.00M 998.00M
Net Income
5.64B 5.24B 5.76B 6.78B
Net Income Growth
-18.88% -7.11% +9.88% +17.78%
Net Margin Growth
+9.37% +8.07% +8.16% +8.97%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
5.64B 5.24B 5.76B 6.78B
Preferred Dividends
- - - -
-
Net Income Available to Common
5.64B 5.24B 5.76B 6.78B
EPS (Basic)
- 19.4353 19.2435 22.2735
EPS (Basic) Growth
- -9.66% -0.99% +15.75%
Basic Shares Outstanding
- 290.35M 272.40M 258.60M
EPS (Diluted)
19.1505 18.9644 22.001 28.3263
EPS (Diluted) Growth
-9.49% -0.97% +16.01% +28.75%
Diluted Shares Outstanding
294.67M 276.41M 261.81M 239.50M
EBITDA
12.02B 12.70B 13.86B 15.49B
EBITDA Growth
-4.06% +5.67% +9.09% +11.75%
EBITDA Margin
+19.96% +19.55% +19.63% +20.49%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 530.30
Number of Ratings 28 Current Quarters Estimate 7.165
FY Report Date 03 / 2026 Current Year's Estimate 30.066
Last Quarter’s Earnings 8.01 Median PE on CY Estimate N/A
Year Ago Earnings 28.21 Next Fiscal Year Estimate 33.137
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 19 19 22 21
Mean Estimate 7.17 7.46 30.07 33.14
High Estimates 7.65 7.78 31.06 34.53
Low Estimate 6.72 7.14 29.10 32.09
Coefficient of Variance 3.24 2.28 1.88 2.39

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 14 14 14
OVERWEIGHT 1 1 1
HOLD 11 11 11
UNDERWEIGHT 1 1 1
SELL 1 1 1
MEAN Overweight Overweight Overweight

Insider Actions for Hca Healthcare Inc. - HCA

Date Name Shares Transaction Value
Nov 20, 2025 Samuel N. Hazen CEO; Director 32,276 Bona fide gift 0.00

Hca Healthcare Inc. in the News